Access cutting-edge obesity treatment through this clinical trial at a research site in Honolulu. Study-provided care at no cost to qualified participants.
Access obesity specialists in Honolulu at no cost
This study follows strict safety protocols and ethical guidelines
All study-related obesity treatment provided free
This study will look at how well CagriSema helps people with obesity lose weight compared to a "dummy medicine". CagriSema is a new medicine developed by Novo Nordisk. CagriSema cannot yet be prescribed by doctors. The study has two parts: First part is called the main phase and will last for 2 years, and second part is called the extension phase and will last for 1 year. In the main phase participants will either get CagriSema or "dummy medicine". Which treatment participants get is decided by
Sponsor: Novo Nordisk A/S
Check if you qualify for this obesity clinical trial in Honolulu, HI
If you're searching for obesity treatment options in Honolulu, HI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Honolulu research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.